Set Your Sights On Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI)’S Upside Potential
Brainstorm Cell Therapeutics, Inc. (BCLI) concluded trading on Wednesday at a closing price of $0.31, with 2.84 million shares of worth about $0.88 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -8.93% during that period and on August 14, 2024 the price saw […]
These Numbers Could Change Investor Views For Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI)
Liberty Wealth Management LLC recently announced the acquisition of new stake in Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI). The institutional investor has increased its shareholding in the Healthcare company by 134.22% to 0.35 million shares with purchase of 0.2 million shares. This fresh investment now brings its stake to 0.72% valued currently at $98381.0. In addition, […]
Brainstorm Cell Therapeutics, Inc. (BCLI) Volatility Spurs A Quest For Clarity
Liberty Wealth Management LLC recently announced the acquisition of new stake in Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI). The institutional investor has increased its shareholding in the Healthcare company by 134.22% to 0.35 million shares with purchase of 0.2 million shares. This fresh investment now brings its stake to 0.78% valued currently at $53951.0. In addition, […]
Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI) – Not A Clear Buying Opportunity?
Liberty Wealth Management LLC has recently announced that it has increased stake in Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) by 134.22%. After grabbing 0.35 million shares, the institutional investor is now in possession of 0.2 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.78% having worth around $53951.0. […]
